3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
22
Phase NA
6
Phase 1/2
6
Phase 2/3
2
Phase 4
1
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
CNS
1
Conditions
Neoplasm Metastasis
1
Glioblastoma
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Interventions
Cisplatin
20
Docetaxel
19
Capecitabine
19
Oxaliplatin
14
Drug Therapy
14
Cyclophosphamide
14
Paclitaxel
13
Fluorouracil
12
Radiotherapy
11
apatinib
9
Gemcitabine
9
Doxorubicin
9
Decitabine
9
Methotrexate
8
Epirubicin
8
Carboplatin
8
sintilimab
6
Etoposide
6
camrelizumab
5
anlotinib
5
XELOX
5
Sorafenib
5
Radiation
5
Pemetrexed
5
Neoadjuvant Therapy
5
Leucovorin
5
Idarubicin
5
Dexamethasone
5
Cytarabine
5
Busulfan
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Unknown
×
Sunitinib
×
Clear all
NCT03025893
2021-04-19
STELLAR
Amsterdam UMC, location VUmc
Phase 2/3
Unknown
100 enrolled
NCT03909724
2020-11-13
SUNRISE-CRC
Amsterdam UMC, location VUmc
Phase 2/3
Unknown
60 enrolled